These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7488407)

  • 1. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.
    Ellis PA; Norman A; Hill A; O'Brien ME; Nicolson M; Hickish T; Cunningham D
    Eur J Cancer; 1995 Sep; 31A(10):1594-8. PubMed ID: 7488407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II study.
    Ferrari VD; Amoroso V; Valcamonico F; Fusi A; Simoncini E; Vasalli L; Rangoni G; Mambrini A; Marpicati P; Montini E; Marini G
    Am J Clin Oncol; 2004 Oct; 27(5):445-8. PubMed ID: 15596907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.
    Geh JI; Glynne-Jones R; Kwok QS; Banerji U; Livingstone JI; Townsend ER; Harrison RA; Mitchell IC
    Clin Oncol (R Coll Radiol); 2000; 12(3):182-7. PubMed ID: 10942336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.
    Lee MA; Woo IS; Kang JH; Hong YS; Lee KS
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):346-50. PubMed ID: 14997381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).
    Findlay M; Cunningham D; Norman A; Mansi J; Nicolson M; Hickish T; Nicolson V; Nash A; Sacks N; Ford H
    Ann Oncol; 1994 Sep; 5(7):609-16. PubMed ID: 7993836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.
    Karapetis CS; Yip D; Virik K; Strickland A; Ryder K; Cowling M; Harper PG
    Med Oncol; 2001; 18(1):23-32. PubMed ID: 11778966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
    Ross P; Nicolson M; Cunningham D; Valle J; Seymour M; Harper P; Price T; Anderson H; Iveson T; Hickish T; Lofts F; Norman A
    J Clin Oncol; 2002 Apr; 20(8):1996-2004. PubMed ID: 11956258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
    Bonnefoi H; Smith IE; O'Brien ME; Seymour MT; Powles TJ; Allum WH; Ebbs S; Baum M
    Br J Cancer; 1996 Feb; 73(3):391-6. PubMed ID: 8562348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.
    Jones AL; Smith IE; O'Brien ME; Talbot D; Walsh G; Ramage F; Robertshaw H; Ashley S
    J Clin Oncol; 1994 Jun; 12(6):1259-65. PubMed ID: 8201387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).
    Andreyev HJ; Norman AR; Cunningham D; Padhani AR; Hill AS; Ross PJ; Webb A
    Eur J Cancer; 1995 Dec; 31A(13-14):2209-14. PubMed ID: 8652244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer.
    Eisen T; Smith IE; Johnston S; Ellis PA; Prendiville J; Seymour MT; Walsh G; Ashley S
    J Clin Oncol; 1998 Apr; 16(4):1350-7. PubMed ID: 9552036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Hepatogastroenterology; 2008; 55(85):1380-4. PubMed ID: 18795694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
    Ocvirk J; Reberšek M; Skof E; Hlebanja Z; Boc M
    Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.
    Cho EK; Lee WK; Lim DY; Bang SM; Park DK; Park YH; Kwon OS; Choi DJ; Shin DB; Lee JH; Lee TH
    J Korean Med Sci; 2002 Jun; 17(3):348-52. PubMed ID: 12068138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
    Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma.
    Cereda S; Passoni P; Reni M; Viganò MG; Aldrighetti L; Nicoletti R; Villa E
    Cancer; 2010 May; 116(9):2208-14. PubMed ID: 20187098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
    Bamias A; Cunningham D; Nicolson V; Norman A; Hill M; Nicolson M; O'Brien M; Webb A; Hill A
    Br J Cancer; 1995 Mar; 71(3):583-6. PubMed ID: 7880742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.